Skip Navigation

European Heart Journal 2001 22(22):2104-2115; doi:10.1053/euhj.2001.2622
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Llevadot, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Llevadot, J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction

J Llevadota,f1, R.P Giuglianoa,f1,f2, E.M Antmana, R.G Wilcoxb, E.P Gurfinkelc, T Henryd, C.H McCabea, A Charlesworthe, S Thompsone, J.C Nicolauf, U Tebbeg, Z Sadowskih and E Braunwald for the InTIME (intraenous nPA for Treatment of Infarcting Myocardium Early) II Invatigatorsa InTIME (intraenous nPA for Treatment of Infarcting Myocardium Early) II Invatigators

a TIMI Study Group, Cardiovascular Division, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
b Division of Cardiovascular Medicine, Queen's Medical Centre, Nottingham, U.K.
c Fundacion Favaloro, Buenos Aires, Argentina
d Hennepin County Medical Center, Minneapolis, MN, U.S.A.
e Nottingham Clinical Research Group, Nottingham, U.K.
f Instituto de Coracao, Sao Paolo, Brasil
g Klinikum Lippe-Detmold, Detmold, Germany
h Klinika Choroby Wiencowej, Warsaw, Poland

revised January 23, 2001; accepted January 24, 2001

Abstract

Aims To compare management and clinical outcomes in hospitals stratified by the availability of on-site catheterization in InTIME-II, a multicentre trial comparing alteplase with lanoteplase for acute myocardial infarction.

Methods and Results We studied 15–078 patients enrolled in 35 countries and 855 hospitals. Thirty-one percent of hospitals had 24-h, 25% day-only, and 44% no on-site catheterization facilities. Rates of cardiac angiography (57%, 38%, 26%) and revascularization (37%, 21%, 17%) were higher in hospitals with increasing access to on-site facilities )

Conclusions There is a marked variation in procedure use by the availability of on-site catheterization with no major differences in patient outcomes. There is a need for additional randomized trials in the current era to address both the appropriate selection of patients and timing of invasive procedures in ST-elevation acute myocardial infarction.

Key Words: Myocardial infarction, fibrinolysis, availability of on-site catheterization, outcomes

f1 These authors contributed equally to the manuscript.

f2 Correspondence: Robert P. Giugliano MD, SM, TIMI Study Office, 333 Longwood Avenue, Suite 402, Boston, MA 02115, U.S.A.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
J. Labarere, L. Belle, M. Fourny, N. Genes, J.-M. Lablanche, D. Blanchard, J.-P. Cambou, N. Danchin, and for the Unite de Soins Intensifs Coronaires 2000 I
Outcomes of Myocardial Infarction in Hospitals With Percutaneous Coronary Intervention Facilities
Arch Intern Med, May 14, 2007; 167(9): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Kashani, R. P. Giugliano, E. M. Antman, D. A. Morrow, C. M. Gibson, S. A. Murphy, and E. Braunwald
Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction
Eur. Heart J., October 1, 2004; 25(19): 1702 - 1710.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. A. Morrow, E. M. Antman, S. A. Murphy, S. F. Assmann, R. P. Giugliano, C. P. Cannon, C. Michael Gibson, C. H. McCabe, H. V. Barron, F. Van de Werf, et al.
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies
Eur. Heart J., July 1, 2004; 25(13): 1139 - 1145.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Alter, J. V. Tu, P. C. Austin, and C. D. Naylor
Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada
J. Am. Coll. Cardiol., August 6, 2003; 42(3): 410 - 419.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Gabriel Steg, B. Iung, L. J Feldman, A. P Maggioni, U. Keil, J. Deckers, D. Cokkinos, K. A.A Fox, and for the ENACT investigators
Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT
Eur. Heart J., April 1, 2003; 24(7): 613 - 622.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Mehta, D. A. Criger, C. B. Granger, K. K. Pieper, R. M. Califf, E. J. Topol, and E. R. Bates
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability
J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1034 - 1040.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. M. Califf and D. L. DeMets
Principles From Clinical Trials Relevant to Clinical Practice: Part I
Circulation, August 20, 2002; 106(8): 1015 - 1021.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. Bakhai, D.P. de Arenaza, and M. Flather
Angiography and revascularization after thrombolysis: where are we?
Eur. Heart J., November 2, 2001; 22(22): 2049 - 2051.
[PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.